1. Home
  2. CINGW vs STRRP Comparison

CINGW vs STRRP Comparison

Compare CINGW & STRRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CINGW
  • STRRP
  • Stock Information
  • Founded
  • CINGW N/A
  • STRRP N/A
  • Country
  • CINGW United States
  • STRRP United States
  • Employees
  • CINGW 13
  • STRRP 171
  • Industry
  • CINGW Biotechnology: Pharmaceutical Preparations
  • STRRP Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CINGW Health Care
  • STRRP Health Care
  • Exchange
  • CINGW Nasdaq
  • STRRP Nasdaq
  • Market Cap
  • CINGW N/A
  • STRRP N/A
  • IPO Year
  • CINGW 2021
  • STRRP N/A
  • Fundamental
  • Price
  • CINGW $0.04
  • STRRP $9.10
  • Analyst Decision
  • CINGW
  • STRRP
  • Analyst Count
  • CINGW 0
  • STRRP 0
  • Target Price
  • CINGW N/A
  • STRRP N/A
  • AVG Volume (30 Days)
  • CINGW N/A
  • STRRP N/A
  • Earning Date
  • CINGW N/A
  • STRRP N/A
  • Dividend Yield
  • CINGW N/A
  • STRRP N/A
  • EPS Growth
  • CINGW N/A
  • STRRP N/A
  • EPS
  • CINGW N/A
  • STRRP N/A
  • Revenue
  • CINGW N/A
  • STRRP N/A
  • Revenue This Year
  • CINGW N/A
  • STRRP N/A
  • Revenue Next Year
  • CINGW N/A
  • STRRP N/A
  • P/E Ratio
  • CINGW N/A
  • STRRP N/A
  • Revenue Growth
  • CINGW N/A
  • STRRP N/A
  • 52 Week Low
  • CINGW N/A
  • STRRP N/A
  • 52 Week High
  • CINGW N/A
  • STRRP N/A
  • Technical
  • Relative Strength Index (RSI)
  • CINGW N/A
  • STRRP 46.18
  • Support Level
  • CINGW N/A
  • STRRP $9.07
  • Resistance Level
  • CINGW N/A
  • STRRP $9.36
  • Average True Range (ATR)
  • CINGW 0.00
  • STRRP 0.05
  • MACD
  • CINGW 0.00
  • STRRP 0.00
  • Stochastic Oscillator
  • CINGW 0.00
  • STRRP 56.67

About CINGW Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

About STRRP Star Equity Holdings Inc. Series A Cumulative Perpetual Preferred Stock

Star Equity Holdings Inc is a multi-industry diversified holding company with two segments: The construction segment manufactures modular housing units for commercial and residential applications. It operates in two businesses: modular building manufacturing and structural wall panel and wood foundation manufacturing, including building supply retail operations, and The investments segment holds corporate-owned real estate, which currently includes two manufacturing facilities in Maine that it leases back to KBS and manufacturing facility. The company derives maximum revenue from Construction Segment.

Share on Social Networks: